AI-Native Drug-Discovery Competitive Positioning for a Top-20 Pharma
A competitive-intelligence review that converted a top-20 pharma's fragmented AI-discovery partnership posture into a structured build-buy- partner framework anchored to clinical-evidence and deal-structure benchmarks.